Skip to main content
logo
Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
16.40
+0.50 (3.14%)
Aug 10, 2026, 4:00 PM EDT - Market closed

Beta Bionics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
119.01100.2565.12120.18
Revenue Growth
52.54%53.94%442.93%6601.12%-
Gross Profit
69.455.5435.896.310.18
Operating Income
-83.02-71.68-45.25-35.85-65.84
Net Income
-72.97-73.2-54.76-44.1-64.75
Earnings Per Share
-1.65-1.81-8.60-8.31-12.96
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash (Debt)
44.3231.5830.4326.5727.68
Net Cash Growth
26.35%3.76%14.55%-4.01%-
Cash & Investments
44.3231.5830.4326.5727.68
Net Cash Per Share
1.000.784.785.015.54

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-55.81-50.93-48.27-32.45-60.21
Capital Expenditures
-5.6-5.3-3.4-0.4-0.77
Free Cash Flow
-61.41-56.22-51.67-32.85-60.98
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
58.31%55.40%55.11%52.59%100.00%
Operating Margin
-69.75%-71.50%-69.48%-298.88%-36784.40%
Pretax Margin
-59.32%-73.02%-84.08%-367.64%-36173.74%
Profit Margin
-61.32%-73.02%-84.08%-367.64%-36173.70%
FCF Margin
-51.60%-56.08%-79.34%-273.84%-34067.00%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
6.2013.48---